HCV HIV +*+ Human immunodeficiency virus HIV hepatitis C virus HCV HIV HCV HCV HIV HIV

Similar documents
Papers. Clinical application of the Quantiplex HCV RNA 2.0 and Amplicor HCV Monitor assays for quantifying serum hepatitis C virus RNA

HIV. KEY WORDS: HIV, esophageal varices, endoscopic injection sclerotherapy (EIS), endoscopic variceal ligation (EVL)

Kenneth E. Sherman, 1 Norah J. Shire, 1 Paul Cernohous, 2 Susan D. Rouster, 1 Janice H. Omachi, 2 Scott Brun, 2 and Barbara Da Silva 2

Changes in Hepatitis C Virus (HCV) Antibody Status in Patients with Chronic Hepatitis C after Eradication of HCV Infection by Interferon Therapy

ABNORMAL LEVELS OF LIVER ENzymes

Evaluation of Interferon Treatment in Cirrhotic Patients with Hepatitis C

: TP6.3 g dl, Alb4.3 g dl, GOT17 IU l, GPT26 IU l,

Over the past decade, the introduction of

Treatment of HCV and HIV coinfection

The medical management of hepatitis C

Survival in patients with HIV infection and viral hepatitis B or C: a cohort study

HIV and Hepatitis C Virus Coinfection: Bad Bedfellows

Healthy Liver Cirrhosis

Clinical Infectious Diseases Advance Access published September 3, 2014

Update on HIV-HCV Epidemiology and Natural History

INFECTION WITH GB VIRUS C AND REDUCED MORTALITY AMONG HIV-INFECTED PATIENTS

Direct acting anti-virals: the near future

Management of HIV/HCV Coinfection: An Update

Research Article Clinical Features of Adult Patients with Acute Hepatitis B Virus Infection Progressing to Chronic Infection

Hepatitis B Diagnosis and Management. Marion Peters University of California San Francisco

ORIGINAL INVESTIGATION. Age-Related Response to Interferon Alfa Treatment in Women vs Men With Chronic Hepatitis C Virus Infection

Impact of HIV on Host-Virus Interactions during Early Hepatitis C Virus Infection

Appendix This appendix was part of the submitted manuscript and has been peer reviewed. It is posted as supplied by the authors.

Comparison of HCV viral load and its genotype distributions in HCV mono- and HIV/HCV co-infected illicit drug users

Genotype Dependence of Hepatitis C Virus Load Measurement in Commercially Available Quantitative Assays

Pegasys Ribavirin

The Influence of HCV Coinfection on Clinical, Immunological and Virological Responses to HAART in HIV-Patients

Prediction of Hepatocellular Carcinoma Incidence Risk by Ultrasound Elastography

906 CID 2005:41 (15 September) HIV/AIDS

The HCV pipeline: Will IFN-free treatment be possible? Heiner Wedemeyer. Hannover Medical School Germany

Relative predictive factors for hepatocellular carcinoma after HBeAg seroconversion in HBV infection

Performance of an automated system for quantification of hepatitis C virus RNA

Peginterferon alpha-2b plus ribavirin for chronic hepatitis C virus mixed genotype infection

Sequential Serum Hepatitis C Viral RNA Levels Longitudinally Assessed by Branched DNA Signal Amplification

Natural History of Chronic Hepatitis B

Role of Hepatitis B Virus Genotypes in Chronic Hepatitis B Exacerbation

HBV Core and Core-Related Antigen Quantitation in Chinese Patients with. Chronic Hepatitis B Genotype B and C Virus Infection

Antiviral therapy guidelines for the general population

Effects and Outcomes of Interferon Treatment in Japanese Hepatitis C Patients

Hepatitis C and HIV. Stanislas Pol

hepatitis B virus B 15% 25 HBsAg B HBV HBsAg 15% 20% HBV HBV 90% 16 HIV HBV

Clinicopathological Conference: Hepatitis C in a Patient With Human Immunodeficiency Virus Infection

HBV, HCV / HIV Coinfection 衛生署疾病管制局中區傳染病防治醫療網王任賢指揮官

29th Viral Hepatitis Prevention Board Meeting

Immunity to Viruses. Patricia Fitzgerald-Bocarsly September 25, 2008

Hepatitis C Virus Genotype 2 may not be detected by the Cobas AmpliPrep/Cobas. TaqMan HCV Test, version 1.0

Antiviral Therapy 11: Hepatobiliary Division, Department of Internal Medicine, Kaohsiung Medical University Hospital, Kaohsiung, Taiwan 2

HBV in HIV Forgotten but not Gone

Hepatitis C virus (HCV) is estimated to infect more than REVIEW

W ith an estimated million people worldwide

ORIGINAL INVESTIGATION. Treatment for Hepatitis C Virus in Human Immunodeficiency Virus Infected Patients

coinfected patients predicts HBsAg clearance during long term exposure to tenofovir

Molecular Epidemiology of Hepatitis D Virus Infection among Injecting Drug Users with and without Human Immunodeficiency Virus Infection in Taiwan

With the advent of highly active antiretroviral therapy

Virological Tools and Monitoring in the DAA Era

Laboratory for Clinical and Biological Studies, University of Miami Miller School of Medicine, Miami, FL, USA.

DTD 1. Hepatitis C and HIV. Douglas T. Dieterich, MD Associate Professor of Medicine NYU School of Medicine

H epatitis C virus (HCV) has emerged as the

Case Rep Gastroenterol 2010;4: DOI: /

Treatment of Hepatitis C in HIV-Coinfected Patients. Vincent Soriano Department of Infectious Diseases Hospital Carlos III Madrid, Spain

La gestione corrente dell infezione cronica da HCV: la progressione verso la cirrosi. Simona Landonio I Div Mal inf H Sacco Milano

Intron A HEPATITIS B. Intron A (interferon alfa-2b) Description

Viral Hepatitis Screening in HIV and Aging

Viral hepatitis in patients living with HIV: can we still speak of special population?

Interferon and ribavirin therapy for chronic hepatitis C virus genotype 6: A comparison with genotype 1

HIV Basics: Clinical Tests and Guidelines

Laboratory and Clinical Diagnosis of HCV Infection

Current Standard of Care for Naïve HCV Patients (SVR)

Performance Characteristics of the COBAS AMPLICOR Hepatitis C Virus MONITOR Test, Version 2.0

High Levels of Hepatitis B Virus After the Onset of Disease Lead to Chronic Infection in Patients With Acute Hepatitis B

Pegasys Pegintron Ribavirin

Interaction between HIV-1 and HCV infections: towards a new entity?

Molecular Diagnosis Future Directions

Hepatitis C virus (HCV) infection frequently

Management of CHC G1 patients who are relapsers or non-responders to Peg IFN and RBV therapy: Wait or Triple Therapy?

D. Posthouwer 1 K. Fischer 1,2 N. de Heusden 1 E.P. Mauser-Bunschoten 1

The Hepatitis B-e antigen-positive

8 Larissa International Congress of Internal Medicine

Fulminant hepatic failure in acute hepatitis C: increased risk in chronic carriers of hepatitis B virus

Long-term follow-up of patients with chronic hepatitis C with sustained virologic response to interferon

Coinfection with HIV and Hepatitis C Virus in Injection Drug Users and Minority Populations

Hepatitis D. Challenges in 2018

Hepatitis C - results in real life

The Changing World of Hepatitis C

Intron A Hepatitis C. Intron A (interferon alfa-2b) Description

HEPATITIS C VIRUS GENOTYPING IN CHRONIC HEPATITIS C PATIENTS

INTERNATIONAL JOURNAL OF PHARMACEUTICAL RESEARCH AND BIO-SCIENCE

Therapeutic strategies for immune reconstitution in acquired immunodeficiency syndrome

Should Elderly CHC Patients (>70 years old) be Treated?

Viral Hepatitis Diagnosis and Management

Hepatitis Delta. Vicente Soriano Infectious Diseases Unit La Paz University Hospital & IdiPAZ Madrid, Spain

CASE REPORT. Introduction

L\\\\\\1 V\\ High dose interferon treatment in chronic hepatitis C. Group A. Group B. Dosage. Treatment period

Follow-up of patients with SVR Lawrence Serfaty Service d Hépatologie, UMR_S 938 Hôpital Saint-Antoine Université Pierre&Marie Curie Paris, France

Caution: Reactivation of Hepatitis B during Hepatitis C Treatment with Direct-Acting Antiviral Therapy

Hepatitis C No Barriers to Cure

Genotype 4. Sanaa Kamal, M.D., Ph.D. Professor. Ain Shams University, Cairo, Egypt Tufts School of Medicine

Hepatitis A virus (HAV) infection that is transmitted

Solomon Taye 1,2* and Mekuria Lakew 2

Immunodeficiency. (2 of 2)

Transcription:

,**- The Japanese Society for AIDS Research The Journal of AIDS Research +0 HIV HCV + + + + + + + + +, +, :HCV HIV HAART / : +*+ +*0,**- Human immunodeficiency virus HIV hepatitis C virus HCV HIV,* HCV HIV HCV HIV HCV HIV HCV highly active antiretroviral therapy HAART HIV HIV HCV HIV HCV + +331 C National Institutes of Health Consensus Development Conference C /,**, HCV HIV, HCV HIV - 1 HCV HIV HAART HCV 2 :.00 2//* 0/ Fax : */, 1..,+12,**-. +3 33 HCV HIV HIV n +* HCV n 0* HCV HIV n,3 - n -*. HAART HCV HIV GPT, IgM, IgA, IgG, B CD. T HIV Amplicor-HIV monitor assay Roche Diagnostic Systems, Tokyo, Japan HCV Quantiplex HCV RNA Chiron, Emeryville, CA Student t test Wilcoxon test, t-test Spearman rank test P *.*/ HAART HIV HCV + HCV HCV HCV HIV HIV HCV HAART GPT, IgM, IgA, IgG, B CD. T., GPT HCV HIV HCV HCV GPT IgM B HCV HIV HCV GPT HCV CD. T HCV HIV HIV HCV HIV IgA HIV HCV HIV HIV +*+ -+

K Hayashi et al. : Liver Damage Related with Hepatitis C and Human Immune Deficiency Coinfection + HAART HCV HIV IgG HIV, HCV - HAART HIV HCV B CD. T HIV CD. T HCV B, HIV HCV GPT, IgM, IgA, IgG, B CD. T HAART., / HAART HCV HIV HIV HIV CD. T HCV HAART B IgM HCV HIV CD. T HCV B HIV T HCV B C HCV HCV HIV 3 HAART HIV HCV HAART HCV HAART HIV HCV HIV HAART HCV +* HAART ++ HCV HIV HCV HCV HIV +32* HIV HCV HIV HCV IFN HIV HAART IFN HCV +,, +- IFN IFN HAART HCV IFN Vento HCV IFN HAART HCV HIV IFN HCV HCV IFN +. HCV HIV IFN IFN HCV HIV HAART HCV HIV + Bica I, McGovern B, Dhar R, Stone D, McGowan K, Scheib R, Snydman DR : Increasing mortality due to end-stage liver disease in patients with human immunodeficiency virus infection. Clin Infect Dis -, :.3,.31,,**+., Thomas DL : Hepatitis C andhuman immunodeficiency virus infection. Hepatology -0 :S,*+,*3,,**,. - Pol S, Vallet-PichardA, Fontaine H : Hepatitis C and +*, -,

The Journal of AIDS Research Vol. / No.,,**- +*- --

K Hayashi et al. : Liver Damage Related with Hepatitis C and Human Immune Deficiency Coinfection +*. -.

The Journal of AIDS Research Vol. / No.,,**-. CD., B cell, HIV RNA, IgA human immune deficiency coinfection at the era of highly active antiretroviral therapy. J Viral Hepat 3 : + 2,,**,.. Bruno R, Sacchi P, Puoti M, Soriano V, Filice G: HCV chronic hepatitis in patients with HIV : clinical management issues. Am J Gastroenterol 31 : +/32 +0*0,,**,. / Maier I, Wu GY : Hepatitis C and HIV co-infection : a review.world J Gastroenterol 2 : /11 /13,,**,. 0 Mohsen AH, Easterbrook P, Taylor CB, Norris S : Hepatitis C and HIV-+ coinfection. Gut /+ : 0*+ 0*2,,**,. 1 Sulkowski MS, Thomas DL : Hepatitis C in the HIV- Infected Person. Ann Intern Med +-2 : +31,*1,,**-. 2 Yokozaki S, Takamatsu J, Nakano I, Katano Y, Toyoda H, Hayashi K, Hayakawa T, Fukuda Y : Immunologic dynamics in hemophiliac patients infected with hepatitis C virus and human immunodeficiency virus : influence of antiretroviral therapy. Blood 30 :.,3-.,33,,***. 3 Eyster ME, Fried MW, Di Bisceglie AM, Goedert JJ : Increasing hepatitis C virus RNA levels in hemophiliacs : Relationship to human immunodeficiency virus infection and liver disease. Blood 2. : +*,* +*,-, +33.. +* Rutschmann OT, Negro F, Hirschel B, Hadengue A, Anwar D, Perrin LH : Impact of treatment with human immunodeficiency virus (HIV) protease inhibitors on hepatitis C viremia in patients coinfected with HIV. J Infect Dis +11 : 12-12/, +332. ++ Vento S, Garofano T, Renzini C, Casali F, Ferraro T, Concia E : Enhancement of hepatitis C virus replication and liver damage in HIV-coinfected patients on antiretroviral combination therapy. AIDS +, : ++0 ++1, +332. +, Toyoda H, Nakano S, Kumada T, Takeda I, Sugiyama K, Osada T, Kiriyama S, Orito E, Mizokami M : Comparison of serum hepatitis C virus RNA concentration by branched DNA probe assay with competitive reverse transcription polymerase chain reaction as a predictor of response to interferon-alpha therapy in chronic hepatitis C patients. J Med Virol.2 : -/. -/3, +330. +- Di Bisceglie AM, Hoofnagle JH : Optimal therapy of hepatitis C. Hepatology -0 :S+,+ +,1,,**,. +. Yoshida H, Arakawa Y, Sata M, Nishiguchi S, Yano M, Fujiyama S, Yamada G, Yokosuka O, Shiratori Y, Omata M : Interferon therapy prolonged life expectancy among chronic hepatitis C patients. Gastroenterology +,- :.2-.3+,,**,. +*/ -/

K Hayashi et al. : Liver Damage Related with Hepatitis C and Human Immune Deficiency Coinfection / GPT, HCV RNA, IgM, IgG +*0-0